Articles

P09 DARPin® molecule MP0250, a new antiangiogenic drug in multiple myeloma: An in vitro and in vivo study

BJH - volume 8, issue Abstract Book BHS, february 2017

K. De Veirman , L. Rao , M.A. Frassanito , V. Desantis , D. Giannico , L. di Marzo , U. Fiedler , A. Harstrick , D. Ribatti , K. Vanderkerken PhD, A. Vacca

Read more

P2.16 Activation of invariant natural killer T cells reduces angiogenesis in the 5T33 multiple myeloma model

BJH - volume 5, issue Abstract Book BHS, january 2014

H. Nur , L. Rao , A. Vacca , D. Elewaut , E. Van Valckenborgh PhD, E. De Bruyne , K. Vanderkerken PhD, E. Menu

Read more